Pacific Biosciences of California, Inc. (PACB)

PACB Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-503.63	-309.85	-306.74	-314.25	-181.22	29.4
Depreciation & Amortization	392.71	53.35	26.53	17.32	11.59	9.3
Other Amortization	-	-	-	-	-	0.13
Asset Writedown & Restructuring Costs	106.3	184.5	-	-	-	-
Loss (Gain) From Sale of Investments	-6.29	-13.04	-12.84	-0.24	4.01	-0.11
Stock-Based Compensation	48.11	71.04	72.12	78.61	73.36	17.53
Other Operating Activities	-165.31	-151.47	20.71	9.32	-39.24	-33.47
Change in Accounts Receivable	-1.23	9.09	-17.83	5.46	-7.17	-1.6
Change in Inventory	2.15	-8.32	-13.84	-33.91	-13.11	-1.62
Change in Accounts Payable	4.39	1.41	0.21	1.03	6.36	-5.07
Change in Unearned Revenue	-2.3	-2.11	-10.42	-3.73	25.74	0.73
Change in Other Net Operating Assets	2.31	-40.65	-17.07	-22.81	8.5	4.28
Operating Cash Flow	-122.79	-206.06	-259.17	-263.21	-111.18	19.5
Capital Expenditures	-3.47	-6.19	-8.84	-16.75	-5.93	-1.04
Cash Acquisitions	-	-	-0.1	-	-319.79	-
Sale (Purchase) of Intangibles	-5	-	-	-0.18	-	-
Investment in Securities	156.13	130.19	13.55	133.01	-352.81	-218.28
Investing Cash Flow	147.66	124	4.6	116.08	-678.53	-219.32
Long-Term Debt Issued	-	-	-	-	895.54	-
Long-Term Debt Repaid	-	-50.69	-1.84	-1.61	-0.36	-16
Net Debt Issued (Repaid)	-50.2	-50.69	-1.84	-1.61	895.18	-16
Issuance of Common Stock	3.43	7.7	204.52	11.23	326.65	233.84
Other Financing Activities	-	-	-93.79	-	-52.25	34
Financing Cash Flow	-46.77	-42.99	108.89	9.62	1,170	251.84
Net Cash Flow	-21.91	-125.04	-145.68	-137.51	379.87	52.02
Free Cash Flow	-126.26	-212.25	-268.02	-279.96	-117.11	18.46
Free Cash Flow Margin	-81.68%	-137.81%	-133.66%	-218.20%	-89.73%	23.40%
Free Cash Flow Per Share	-0.43	-0.77	-1.06	-1.25	-0.57	0.11
Cash Interest Paid	14.81	14.81	15.69	14.05	6.93	0.49
Levered Free Cash Flow	92.04	-95.64	-311.67	46.5	-24.54	-39.58
Unlevered Free Cash Flow	97.02	-87.26	-302.7	55.68	-16.71	-39.54
Change in Working Capital	5.32	-40.58	-58.96	-53.97	20.33	-3.29

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q